Yizhou Jiang

Engaged in multi-omics research on breast cancer, establishing the first four-subtype system to guide individualized treatment of triple-negative breast cancer – “Fudan Classification”. In recent years, has published multiple articles as first/corresponding author in Cancer Cell, Cell Metabolism, Cell Research and other journals.